Skip to content
53

ivermectin injectable

Worth a look

Shows low returns (0.2%), but soft demand (-9.9% this quarter) keeps it on the watch list.

Market size 69Growth 20Conversion 39Competition 43Returns 99Price range 95Avg price 95Brand share 49Review moat 49Quality gap 22

Returns

Incredible0.2%

return rate — above 5% kills the launch gate

Avg price

Incredible$39.24

avg listing price — sweet spot $15–$100

Price range

Incredible$24.33–$90.90

cheapest to priciest tracked listing — scored on the share inside $15–$100

Market size

Good$716K

$716K/yr · 590K searches

Brand share

Okay75%

top-5 brand share — brands hold most of the demand

Review moat

Okay1,638.85

avg incumbent reviews — the moat a new listing must climb

Competition

Okay59%

top-5 click share — leaders hold, buyers still browse

Conversion

Okay3.1%

search→purchase rate — share of searches ending in a sale

Quality gap

Bad4.7★

avg incumbent rating — lower means beatable quality

Growth

Bad-9.9%

90-day search growth — must beat 0% to launch

Reviews